Literature DB >> 10969937

Transparahippocampal selective amygdalohippocampectomy in children and adolescents: efficacy of the procedure and cognitive morbidity in patients.

S Robinson1, T S Park, L B Blackburn, B F Bourgeois, S T Arnold, W E Dodson.   

Abstract

OBJECT: Unilateral resection of the hippocampus and amygdala can be used to treat medically intractable mesial temporal lobe seizures. To date seizure outcome and the extent of cognitive morbidity have been unknown in children following the transparahippocampal variation of selective amygdalohippocampectomy (TSA), which prompted the present prospective study.
METHODS: Preoperative examinations and outcomes in 22 consecutive children and adolescents who underwent TSA were studied. Cognitive and psychological morbidity were assessed using standard neuropsychological instruments. The authors evaluated relationships between seizure control and cognitive morbidity and 13 and nine clinical variables, respectively. Seizure control was achieved in 11 (65%) of 17 patients (>2 years follow up). Among 13 clinical variables, the only preoperative finding that had a significant bearing on seizure control was the presence of unilateral hypometabolism, which could be observed on [18F]fluorodeoxyglucose-positron emission tomography scans (p<0.001). Patients with seizure control showed significant improvements in verbal and full scale intelligence quotients (both p = 0.05). Patients with longer preoperative durations of seizures exhibited more cognitive impairment that persisted postoperatively. Cognitive outcome analysis based on nine clinical factors revealed no significant difference in cognitive parameters postoperatively, except that significant improvement occurred in rote verbal memory scores among patients who underwent right-sided TSA (p = 0.01). Individually, 81% of the children achieved significant improvement in at least one of seven cognitive parameters, and 52% had stable or improved scores in all parameters.
CONCLUSIONS: The results indicate that TSA is a safe effective approach for the treatment of medically intractable mesial temporal lobe seizures in children with minimum effect on cognitive morbidity. Given that the literature suggests that children suffer progressive cognitive morbidity from persistent seizures, the results of this study support early surgical intervention for this group of children.

Entities:  

Mesh:

Year:  2000        PMID: 10969937     DOI: 10.3171/jns.2000.93.3.0402

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  8 in total

Review 1.  Neuropsychological deficits in childhood epilepsy syndromes.

Authors:  William S MacAllister; Sarah G Schaffer
Journal:  Neuropsychol Rev       Date:  2007-10-26       Impact factor: 7.444

2.  Cognitive assessment in epilepsy surgery of children.

Authors:  D Battaglia; D Chieffo; D Lettori; F Perrino; C Di Rocco; F Guzzetta
Journal:  Childs Nerv Syst       Date:  2006-07-12       Impact factor: 1.475

Review 3.  Temporal lobe resections.

Authors:  William Harkness
Journal:  Childs Nerv Syst       Date:  2006-07-11       Impact factor: 1.475

Review 4.  Surgical strategies for pediatric epilepsy.

Authors:  Jian Guan; Michael Karsy; Katrina Ducis; Robert J Bollo
Journal:  Transl Pediatr       Date:  2016-04

Review 5.  Surgical treatment of epilepsy.

Authors:  John W Miller; Shahin Hakimian
Journal:  Continuum (Minneap Minn)       Date:  2013-06

6.  Temporal lobe epilepsy surgery in children versus adults: from etiologies to outcomes.

Authors:  Yun-Jin Lee; Joon Soo Lee
Journal:  Korean J Pediatr       Date:  2013-07-19

Review 7.  Quantitative Meta-Analyses: Lateralization of Memory Functions Before and After Surgery in Children with Temporal Lobe Epilepsy.

Authors:  Naomi Kahana Levy; Jonathan Segalovsky; Mony Benifla; Odelia Elkana
Journal:  Neuropsychol Rev       Date:  2021-03-06       Impact factor: 7.444

8.  Surgical techniques for the treatment of temporal lobe epilepsy.

Authors:  Faisal Al-Otaibi; Saleh S Baeesa; Andrew G Parrent; John P Girvin; David Steven
Journal:  Epilepsy Res Treat       Date:  2012-03-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.